- Home
- CLLS vs OOMA Comparison
CLLS vs OOMA Comparison
Compare CLLS & OOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- OOMA
- Stock Information
- Founded
- CLLS 1999
- OOMA 2003
- Country
- CLLS France
- OOMA United States
- Employees
- CLLS N/A
- OOMA N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- OOMA EDP Services
- Sector
- CLLS Health Care
- OOMA Technology
- Exchange
- CLLS Nasdaq
- OOMA Nasdaq
- Market Cap
- CLLS 299.0M
- OOMA 345.3M
- IPO Year
- CLLS 2007
- OOMA 2015
- Fundamental
- Price
- CLLS $3.15
- OOMA $12.93
- Analyst Decision
- CLLS Buy
- OOMA Strong Buy
- Analyst Count
- CLLS 1
- OOMA 5
- Target Price
- CLLS $4.00
- OOMA $17.63
- AVG Volume (30 Days)
- CLLS 76.4K
- OOMA 191.0K
- Earning Date
- CLLS 11-03-2025
- OOMA 08-26-2025
- Dividend Yield
- CLLS N/A
- OOMA N/A
- EPS Growth
- CLLS N/A
- OOMA N/A
- EPS
- CLLS N/A
- OOMA N/A
- Revenue
- CLLS $63,438,000.00
- OOMA $261,617,000.00
- Revenue This Year
- CLLS N/A
- OOMA $6.33
- Revenue Next Year
- CLLS $66.76
- OOMA $6.15
- P/E Ratio
- CLLS N/A
- OOMA N/A
- Revenue Growth
- CLLS 223.09
- OOMA 5.42
- 52 Week Low
- CLLS $1.10
- OOMA $10.88
- 52 Week High
- CLLS $3.35
- OOMA $17.00
- Technical
- Relative Strength Index (RSI)
- CLLS 54.47
- OOMA 54.27
- Support Level
- CLLS N/A
- OOMA $12.43
- Resistance Level
- CLLS $3.35
- OOMA $12.83
- Average True Range (ATR)
- CLLS 0.15
- OOMA 0.31
- MACD
- CLLS -0.09
- OOMA -0.69
- Stochastic Oscillator
- CLLS 94.03
- OOMA 97.05
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About OOMA Ooma Inc.
Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.